Understanding Cancer Immunotherapy Medical Advisory Board Find a treatment facility near you

Our Medical Advisory Board
Learn more about our distinguished medical advisory board members.
Understanding Cancer Immunotherapy
Learn about the innovative new therapies reshaping cancer treatment with this FREE guide.
Featured Survivors
Read inspiring personal stories from cancer patients.
Find financial and advocacy help for your cancer journey.
Treatment Facilities
Locate a cancer center close to home.
Patient Matching
Get matched with another patient with your cancer type.


Reader Survey
Let us know how we are doing!
Patient Marketplace
Shop for cancer-related products to help you during and after treatment.
Clinical Trials
Search nationwide databases for cancer trials.

Latest Cancer News

FDA approves new therapy for certain types of advanced soft tissue sarcoma: The U.S. Food and Drug Administration today approved Yondelis (trabectedin), a chemotherapy, for the treatment of specific soft tissue sarcomas -(STS)liposarcoma and leiomyosarcoma.

SITC Celebrates U.S. Food & Drug Administration Approval of First Combination Immunotherapy for the Treatment of Cancer: First combination immunotherapy for metastatic melanoma is approved.

FDA approves Keytruda for advanced non-small cell lung cancer: First drug approved in lung cancer for patients whose tumors express PD-L1.

Scientists identify another frequently mutated gene in melanoma: New marker thought to be 'major player' in development of deadly skin cancer.

Molecule found that helps BRCA gene resist cancer treatment: Yale team says without molecule BRCA2 mutations cannot do their job of repairing DNA, which is key to the survival of cancer cells.

Genomic discovery of skin cancer subtypes provides potential 'signpost' for drug targets: Five-year study results show promise for melanoma treatment.

Register Now! Sign Up For Our Free E-Newletter!

Read Inspiring Cancer Survivor Stories

Order Your Guides Here